Pulmonx shares rise 10.25% intraday after filing $200M mixed shelf registration.

Pulmonx Corporation (NASDAQ: LUNG) rose 10.25% intraday following the announcement of a $200 million mixed shelf filing for common stock, preferred stock, debt securities, and warrants. The move, which occurred during regular trading hours, reflects the company’s strategy to expand capital-raising flexibility, potentially signaling confidence in future growth opportunities or operational needs. The market’s positive reaction suggests investor optimism about Pulmonx’s ability to leverage additional funding for strategic initiatives, such as product development or market expansion. The filing itself is a procedural step but is often interpreted as a precursor to significant corporate actions that could enhance shareholder value.